These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 12383223)
21. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression. Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420 [TBL] [Abstract][Full Text] [Related]
22. Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators. Kotsinas A; Evangelou K; Zacharatos P; Kittas C; Gorgoulis VG Am J Pathol; 2002 Nov; 161(5):1619-34. PubMed ID: 12414510 [TBL] [Abstract][Full Text] [Related]
23. alpha-, beta- and chi-catenin expression in human pancreatic cancer. Julkunen K; Mäkinen K; Kärjä V; Kosma VM; Eskelinen M Anticancer Res; 2003; 23(6D):5043-7. PubMed ID: 14981965 [TBL] [Abstract][Full Text] [Related]
24. Biochemical analysis and subcellular distribution of E-cadherin-catenin in adenocarcinomas of the gastro-oesophageal junction. Wijnhoven BP; Tucker ET; Dinjens WN; Tilanus HW; Pignatelli M Anticancer Res; 2004; 24(3a):1369-75. PubMed ID: 15274297 [TBL] [Abstract][Full Text] [Related]
25. Nuclear translocation of beta-catenin in colorectal cancer. Kobayashi M; Honma T; Matsuda Y; Suzuki Y; Narisawa R; Ajioka Y; Asakura H Br J Cancer; 2000 May; 82(10):1689-93. PubMed ID: 10817505 [TBL] [Abstract][Full Text] [Related]
26. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer. Lim SC; Lee MS Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114 [TBL] [Abstract][Full Text] [Related]
28. Abnormal expression of E-cadherin in early gastric carcinoma: its relationship with macroscopic growth patterns and catenin alpha and beta. Song SY; Kim S; Kim DS; Son HJ; Rhee JC; Kim YI J Clin Gastroenterol; 2004 Mar; 38(3):252-9. PubMed ID: 15128072 [TBL] [Abstract][Full Text] [Related]
29. Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines. Jawhari AU; Noda M; Farthing MJ; Pignatelli M Br J Cancer; 1999 May; 80(3-4):322-30. PubMed ID: 10408833 [TBL] [Abstract][Full Text] [Related]
30. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141 [TBL] [Abstract][Full Text] [Related]
31. Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas. Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Ferreira VM; Lopes CS Hum Pathol; 2004 Jun; 35(6):663-9. PubMed ID: 15188131 [TBL] [Abstract][Full Text] [Related]
32. Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus. Osterheld MC; Bian YS; Bosman FT; Benhattar J; Fontolliet C Am J Clin Pathol; 2002 Mar; 117(3):451-6. PubMed ID: 11888085 [TBL] [Abstract][Full Text] [Related]
33. Correlation of cytoplasmic beta-catenin and cyclin D1 overexpression during thyroid carcinogenesis around Semipalatinsk nuclear test site. Meirmanov S; Nakashima M; Kondo H; Matsufuji R; Takamura N; Ishigaki K; Ito M; Prouglo Y; Yamashita S; Sekine I Thyroid; 2003 Jun; 13(6):537-45. PubMed ID: 12930597 [TBL] [Abstract][Full Text] [Related]
34. Expression patterns of beta-catenin in in situ and invasive breast cancer. Karayiannakis AJ; Nakopoulou L; Gakiopoulou H; Keramopoulos A; Davaris PS; Pignatelli M Eur J Surg Oncol; 2001 Feb; 27(1):31-6. PubMed ID: 11237489 [TBL] [Abstract][Full Text] [Related]
35. The expression and prognostic value of alpha-, beta- and gamma-catenins in renal cell carcinoma. Aaltomaa S; Lipponen P; Kärjä V; Lundstedt S; Lappi J; Kosma VM Anticancer Res; 2004; 24(4):2407-13. PubMed ID: 15330191 [TBL] [Abstract][Full Text] [Related]
36. Relation of E-cadherin and beta-catenin expression to pit pattern in colorectal cancer. Kojima M; Shiokawa A; Ohike N; Tamegai Y; Kato H; Morohoshi T Oncol Rep; 2004 Sep; 12(3):533-8. PubMed ID: 15289833 [TBL] [Abstract][Full Text] [Related]
37. E-cadherin and catenins in early squamous cervical carcinoma. Van de Putte G; Kristensen GB; Baekelandt M; Lie AK; Holm R Gynecol Oncol; 2004 Aug; 94(2):521-7. PubMed ID: 15297198 [TBL] [Abstract][Full Text] [Related]
38. P53 and beta-catenin in colorectal cancer progression. Valentini AM; Pirrelli M; Renna L; Armentano R; Caruso ML Curr Pharm Des; 2003; 9(24):1932-6. PubMed ID: 12871177 [TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations. Fernebro E; Bendahl PO; Dictor M; Persson A; Fernö M; Nilbert M Int J Cancer; 2004 Oct; 111(6):921-8. PubMed ID: 15300804 [TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase 2, p53, beta-catenin, and APC protein expression in gastric adenomatous polyps. Smith GV; Feakins R; Farthing MJ; Ballinger A Am J Clin Pathol; 2005 Mar; 123(3):415-20. PubMed ID: 15716238 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]